Breaking News Instant updates and real-time market news.

KIM

Kimco Realty

$26.07

-0.02 (-0.08%)

08:52
11/25/16
11/25
08:52
11/25/16
08:52

Kimco Realty upgraded to Buy from Hold at Argus

Argus analyst Jacob Kilstein upgraded Kimco Realty to Buy with a $30 price target saying the company has transformed into a pure-play U.S. retail REIT as it exits Canada and all joint ventures and expects it to generate 7% FFO growth in 2017, after three years of 4%-5% growth. Kilstein said the company has re-positioned its portfolio through asset sales and believes that its focus on redeveloping high-quality shopping centers will support dividend growth and in same-property net operating income.

  • 03

    Feb

KIM Kimco Realty
$26.07

-0.02 (-0.08%)

04/14/16
MZHO
04/14/16
INITIATION
Target $28.5
MZHO
Neutral
Kimco Realty initiated with a Neutral at Mizuho
Target $28.50.
06/28/16
BOSC
06/28/16
INITIATION
BOSC
Neutral
Kimco Realty initiated with a Neutral at Boenning & Scattergood
07/07/16
SBSH
07/07/16
DOWNGRADE
Target $32
SBSH
Neutral
Kimco Realty downgraded to Neutral from Buy at Citi
Citi analyst Michael Bilerman downgraded Kimco Realty to Neutral citing valuation following the recent outperformance of the shares. The analyst keeps a $32 price target for the name.
08/25/16
BTIG
08/25/16
INITIATION
Target $34
BTIG
Buy
Kimco Realty initiated with a Buy at BTIG
BTIG analyst James Sullivan initiated Kimco Realty with a Buy and $34 price target saying recent steps to exit Canada and repay high-cost debt, coupled with the development pipeline should boost results through 2017.

TODAY'S FREE FLY STORIES

MIK

Michaels

$24.31

0.34 (1.42%)

07:07
12/06/16
12/06
07:07
12/06/16
07:07
Hot Stocks
Michaels announces increase of share repurchase program by $300M »

In December 2016, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

PFG

Principal Financial

$59.47

1.69 (2.92%)

07:06
12/06/16
12/06
07:06
12/06/16
07:06
Conference/Events
Principal Financial to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

SPPI

Spectrum

$4.03

0.03 (0.75%)

07:06
12/06/16
12/06
07:06
12/06/16
07:06
Hot Stocks
Spectrum highlights survival advantage in case match control analysis of PROPEL »

Spectrum Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 11

    Dec

PLUG

Plug Power

$1.47

0.04 (2.80%)

07:06
12/06/16
12/06
07:06
12/06/16
07:06
Initiation
Plug Power initiated  »

Plug Power initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

PSTI

Pluristem

$1.55

0.08 (5.44%)

07:06
12/06/16
12/06
07:06
12/06/16
07:06
Hot Stocks
Pluristem PLX-R18 advances into second cohort of study for ARS »

Pluristem Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPP

Green Plains Partners

$17.85

-0.15 (-0.83%)

07:06
12/06/16
12/06
07:06
12/06/16
07:06
Upgrade
Green Plains Partners rating change  »

Green Plains Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$25.82

-0.07 (-0.27%)

07:05
12/06/16
12/06
07:05
12/06/16
07:05
Hot Stocks
AstraZeneca says data presented shows TAGRISSO superiority over chemotherapy »

AstraZeneca presented…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 16

    Feb

EARS

Auris Medical

07:05
12/06/16
12/06
07:05
12/06/16
07:05
Hot Stocks
Auris Medical on track to resume enrollment of Keyzilen Phase 3 trial »

Auris Medical Holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNCR

Synchronoss

$49.00

1.81 (3.84%)

, IL

Intralinks

$11.27

0.11 (0.99%)

07:04
12/06/16
12/06
07:04
12/06/16
07:04
Earnings
Synchronoss sees FY17 pro forma EPS $2.45-$2.60 for combined entity »

May not compare to…

SNCR

Synchronoss

$49.00

1.81 (3.84%)

IL

Intralinks

$11.27

0.11 (0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 12

    Dec

  • 13

    Dec

CHTR

Charter

$270.93

4.26 (1.60%)

07:04
12/06/16
12/06
07:04
12/06/16
07:04
Initiation
Charter initiated  »

Charter initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

MDGN

Medgenics

07:04
12/06/16
12/06
07:04
12/06/16
07:04
Initiation
Medgenics initiated  »

Medgenics initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

AM

Antero Midstream

$28.48

-0.1 (-0.35%)

07:04
12/06/16
12/06
07:04
12/06/16
07:04
Upgrade
Antero Midstream rating change  »

Antero Midstream upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSBC

HSBC

$39.86

0.17 (0.43%)

07:03
12/06/16
12/06
07:03
12/06/16
07:03
Upgrade
HSBC rating change  »

HSBC upgraded to Equal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGTX

TG Therapeutics

$5.70

0.2 (3.64%)

07:03
12/06/16
12/06
07:03
12/06/16
07:03
Hot Stocks
TG Therapeutics GENUINE Phase 3 study reaches target enrollment »

TG Therapeutics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNCR

Synchronoss

$49.00

1.81 (3.84%)

07:03
12/06/16
12/06
07:03
12/06/16
07:03
Hot Stocks
Synchronoss to divest part of activation business to Sequential for $146M »

Synchronoss is also…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

SNCR

Synchronoss

$49.00

1.81 (3.84%)

, IL

Intralinks

$11.27

0.11 (0.99%)

07:03
12/06/16
12/06
07:03
12/06/16
07:03
Hot Stocks
Synchronoss to acquire Intralinks for $13/share, or $821M in equity value »

Synchronoss Technologies…

SNCR

Synchronoss

$49.00

1.81 (3.84%)

IL

Intralinks

$11.27

0.11 (0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 12

    Dec

  • 13

    Dec

TEVA

Teva

$37.04

0.51 (1.40%)

07:02
12/06/16
12/06
07:02
12/06/16
07:02
Recommendations
Teva analyst commentary  »

Wells views departure of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Apr

NVCN

Neovasc

$1.42

0.56 (65.12%)

07:02
12/06/16
12/06
07:02
12/06/16
07:02
Hot Stocks
Neovasc provides update on Tiara transcatheter mitral valve »

Neovasc provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDS

GDS Holdings

$9.93

-0.07 (-0.70%)

07:02
12/06/16
12/06
07:02
12/06/16
07:02
Initiation
GDS Holdings initiated  »

GDS Holdings initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNCR

Synchronoss

$49.00

1.81 (3.84%)

, IL

Intralinks

$11.27

0.11 (0.99%)

07:02
12/06/16
12/06
07:02
12/06/16
07:02
Hot Stocks
Breaking Hot Stocks news story on Synchronoss, Intralinks »

Synchronoss to acquire…

SNCR

Synchronoss

$49.00

1.81 (3.84%)

IL

Intralinks

$11.27

0.11 (0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 12

    Dec

  • 13

    Dec

KKR

KKR

$15.67

0.19 (1.23%)

, BX

Blackstone

$26.40

0.54 (2.09%)

07:01
12/06/16
12/06
07:01
12/06/16
07:01
Hot Stocks
KKR to acquire Optiv Security from investors, including fund managed by Blackstone »

Optiv Security, a…

KKR

KKR

$15.67

0.19 (1.23%)

BX

Blackstone

$26.40

0.54 (2.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

  • 12

    Dec

  • 13

    Dec

AZO

AutoZone

$776.42

-7.32 (-0.93%)

07:00
12/06/16
12/06
07:00
12/06/16
07:00
Earnings
AutoZone reports Q1 EPS $9.36, consensus $9.31 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 14

    Dec

ROP

Roper Technologies

$181.64

-0.68 (-0.37%)

, PROJ

Deltek

06:59
12/06/16
12/06
06:59
12/06/16
06:59
Hot Stocks
Roper Technologies to buy Deltek in all cash transaction valued at $2.8B »

Roper Technologies (ROP)…

ROP

Roper Technologies

$181.64

-0.68 (-0.37%)

PROJ

Deltek

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$228.55

5.19 (2.32%)

06:59
12/06/16
12/06
06:59
12/06/16
06:59
Periodicals
Goldman Sachs leads financing round in Canadian startup Hubba, WSJ says »

Goldman Sachs led a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

ROP

Roper Technologies

$181.64

-0.68 (-0.37%)

, PROJ

Deltek

06:57
12/06/16
12/06
06:57
12/06/16
06:57
Hot Stocks
Breaking Hot Stocks news story on Roper Technologies, Deltek »

Roper Technologies to buy…

ROP

Roper Technologies

$181.64

-0.68 (-0.37%)

PROJ

Deltek

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.